Niche Focus Leverage NeuroDetect's specialization in pediatric traumatic brain injury and post-traumatic epilepsy to reach academic medical centers, pediatric neurology clinics, and CROs with biomarker discovery or companion diagnostics opportunities.

Device Collaboration The development of a wireless EEG system aligns the software platform with hardware for integrated neurodiagnostic solutions; pursue joint sales with hospitals and labs seeking end-to-end monitoring and biomarker profiling.

Translational Value A translational platform spanning in vitro and in vivo approaches enables partnerships with biotech and pharma exploring translational biomarkers for therapeutics, implants, and non-invasive neural interfaces.

Partnership Potential A small team with a history of collaboration at leading research facilities signals openness to co-development agreements; target universities, research institutes, and device makers for rapid validation and market access.

Growth Opportunity Current revenue range suggests room to scale by selling scalable ML-driven biomarker profiling to mid-sized labs and CROs, expanding beyond pediatric TBI into broader neurological conditions and clinical trials.